Skip to content
News
Anal Cancer
Bladder Cancer
Bone Cancer
Brain Cancer
Breast Cancer
Cancer of Unknown Primary
Cervical Cancer
Colon Cancer
Esophageal Cancer
Gastric Cancer
GIST
Head & Neck Cancer
Hodgkins Lymphoma
Leukemia
Acute Leukemia
Chronic Lymphocytic Leukemia
Chronic Myeloid Leukemia
Liver Cancer
Lung Cancer
Melanoma
Mesothelioma
Multiple Myeloma
Myelodysplastic Syndrome
MPN-PV-ET-MF
Neuroblastoma
Neuroendocrine Tumors
Non Hodgkins Lymphoma
Ovarian Cancer
Pancreatic Cancer
Prostate Cancer
Renal Cancer
Rectal Cancer
Sarcoma
Skin Care
Skin Cancer
Testicular Cancer
Thyroid Cancer
Triple Negative Breast Cancer
Uterine Cancer
About Us
Advertising
News
Newly Diagnosed
Treatment & Care
Survivorship
Join the Community
Newsletter
Search
Signatera
May 18, 2026
Atezolizumab Plus ctDNA MRD Testing Wins FDA Approval to Improve Outcomes in Muscle-Invasive Bladder Cancer
Dr. C H Weaver MD
August 29, 2025
Treatment of Stage I – III Colon Cancer
Dr. C H Weaver MD
August 28, 2025
MRD ctDNA Surveillance for Breast Cancer Recurrence
Dr. C H Weaver MD
June 28, 2025
Liquid Biopsy Detects Cancer Progression Much Earlier Than Imaging
Dr. C H Weaver MD
August 12, 2024
New, Effective Tests Might Increase the Numbers of People Screening for Colorectal Cancer
Dr. C H Weaver MD
August 9, 2024
Ask the Experts About Circulating Tumor DNA in the Management of Colorectal Cancer
Dr. C H Weaver MD
August 9, 2024
Ask The Expert About Immunotherapy Treatment for Melanoma
Dr. C H Weaver MD
December 9, 2020
Liquid Biopsies Improve Treatment of Lung Cancer
Dr. C H Weaver MD
Loading Comments...
Write a Comment...
Email (Required)
Name (Required)
Website